254 related articles for article (PubMed ID: 24447368)
21. Membrane pathology and microglial activation of mice expressing membrane anchored or membrane released forms of Aβ and mutated human Alzheimer's precursor protein (APP).
Jeffrey M; McGovern G; Barron R; Baumann F
Neuropathol Appl Neurobiol; 2015 Jun; 41(4):458-70. PubMed ID: 25131655
[TBL] [Abstract][Full Text] [Related]
22. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.
Tribouillard-Tanvier D; Striebel JF; Peterson KE; Chesebro B
J Virol; 2009 Nov; 83(21):11244-53. PubMed ID: 19710140
[TBL] [Abstract][Full Text] [Related]
23. Two alternative pathways for generating transmissible prion disease de novo.
Makarava N; Savtchenko R; Baskakov IV
Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
[TBL] [Abstract][Full Text] [Related]
24. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
25. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
26. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
27. Intraspecies prion transmission results in selection of sheep scrapie strains.
Yokoyama T; Masujin K; Schmerr MJ; Shu Y; Okada H; Iwamaru Y; Imamura M; Matsuura Y; Murayama Y; Mohri S
PLoS One; 2010 Nov; 5(11):e15450. PubMed ID: 21103326
[TBL] [Abstract][Full Text] [Related]
28. Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
Jeffrey M; Goodsir CM; Race RE; Chesebro B
Ann Neurol; 2004 Jun; 55(6):781-92. PubMed ID: 15174012
[TBL] [Abstract][Full Text] [Related]
29. Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.
Mahal SP; Jablonski J; Suponitsky-Kroyter I; Oelschlegel AM; Herva ME; Oldstone M; Weissmann C
PLoS Pathog; 2012; 8(6):e1002746. PubMed ID: 22685404
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human prion protein inhibits prion propagation in vitro.
Yuan J; Zhan YA; Abskharon R; Xiao X; Martinez MC; Zhou X; Kneale G; Mikol J; Lehmann S; Surewicz WK; Castilla J; Steyaert J; Zhang S; Kong Q; Petersen RB; Wohlkonig A; Zou WQ
Sci Rep; 2013 Oct; 3():2911. PubMed ID: 24105336
[TBL] [Abstract][Full Text] [Related]
31. Post-translational modifications in PrP expand the conformational diversity of prions in vivo.
Aguilar-Calvo P; Xiao X; Bett C; Eraña H; Soldau K; Castilla J; Nilsson KP; Surewicz WK; Sigurdson CJ
Sci Rep; 2017 Mar; 7():43295. PubMed ID: 28272426
[TBL] [Abstract][Full Text] [Related]
32. Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.
Kovacs GG; Makarava N; Savtchenko R; Baskakov IV
Am J Pathol; 2013 Nov; 183(5):1539-1547. PubMed ID: 24012784
[TBL] [Abstract][Full Text] [Related]
33. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
34. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
35. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
36. A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases.
Bajsarowicz K; Ahn M; Ackerman L; Dearmond BN; Carlson G; DeArmond SJ
J Neuropathol Exp Neurol; 2012 May; 71(5):449-66. PubMed ID: 22507918
[TBL] [Abstract][Full Text] [Related]
37. Altered trafficking of abnormal prion protein in atypical scrapie: prion protein accumulation in oligodendroglial inner mesaxons.
Jeffrey M; González L; Simmons MM; Hunter N; Martin S; McGovern G
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):215-226. PubMed ID: 26750308
[TBL] [Abstract][Full Text] [Related]
38. Subclinical prion disease induced by oral inoculation.
Thackray AM; Klein MA; Bujdoso R
J Virol; 2003 Jul; 77(14):7991-8. PubMed ID: 12829838
[TBL] [Abstract][Full Text] [Related]
39. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
[TBL] [Abstract][Full Text] [Related]
40. Towards authentic transgenic mouse models of heritable PrP prion diseases.
Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
